JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M003147200 on June 30, 2000

J. Biol. Chem., Vol. 275, Issue 37, 28562-28568, September 15, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/37/28562    most recent
M003147200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Rossum, D. B.
Right arrow Articles by Gill, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Rossum, D. B.
Right arrow Articles by Gill, D. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Ca2+ Entry Mediated by Store Depletion, S-Nitrosylation, and TRP3 Channels

COMPARISON OF COUPLING AND FUNCTION*

Damian B. van RossumDagger, Randen L. PattersonDagger, Hong-Tao Ma, and Donald L. Gill§

From the Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland 21201

Received for publication, April 12, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The mechanism for coupling between Ca2+ stores and store-operated channels (SOCs) is an important but unresolved question. SOC-mediated Ca2+ entry is complex and may reflect more than one type of channel and coupling mechanism. To assess such possible divergence the function and coupling of SOCs was compared with two other distinct yet related Ca2+ entry mechanisms. SOC coupling in DDT1MF-2 smooth muscle cells was prevented by the permeant inositol 1,4,5-trisphosphate (InsP3) receptor blockers, 2-aminoethoxydiphenyl borate (2-APB) and xestospongin C. In contrast, Ca2+ entry induced by S-nitrosylation and potentiated by store depletion (Ma, H-T., Favre, C. J., Patterson, R. L., Stone, M. R., and Gill, D. L. (1999) J. Biol. Chem. 274, 35318-35324) was unaffected by 2-APB, suggesting that this entry mechanism is independent of InsP3 receptors. The cycloalkyl lactamimide, MDL-12,330A (MDL), prevented SOC activation (IC50 10 µM) and similarly completely blocked S-nitrosylation-mediated Ca2+ entry. Ca2+ entry mediated by the TRP3 channel stably expressed in HEK293 cells was activated by phospholipase C-coupled receptors but independent of Ca2+ store depletion (Ma, H.-T., Patterson, R. L., van Rossum, D. B., Birnbaumer, L., Mikoshiba, K., and Gill, D. L. (2000) Science 287, 1647-1651). Receptor-induced TRP3 activation was 2-APB-sensitive and fully blocked by MDL. Direct stimulation of TRP3 channels by the permeant diacylglycerol derivative, 1-oleoyl-2-acetyl-sn-glycerol, was not blocked by 2-APB, but was again prevented by MDL. The results indicate that although the activation and coupling processes for each of the three entry mechanisms are distinct, sensitivity to MDL is a feature shared by all three mechanisms, suggesting there may be a common structural feature in the channels themselves or an associated regulatory component.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Ca2+ signals control many cellular functions ranging from short term responses such as contraction and secretion to longer term regulation of cell growth and proliferation (1). Receptor-induced cytosolic Ca2+ signals are complex involving two closely coupled components: rapid, transient release of Ca2+ stored in the endoplasmic reticulum (ER),1 followed by slowly developing extracellular Ca2+ entry (1-5). G protein-coupled receptors and tyrosine kinase receptors, through activation of phospholipase C, generate the second messenger, inositol 1,4,5-trisphosphate (InsP3), which diffuses rapidly within the cytosol to interact with InsP3 receptors on the ER that serve as Ca2+ channels to release luminal stored Ca2+ and generate the initial Ca2+ signal phase (1, 3). The resulting depletion of Ca2+ stored within the ER lumen serves as the primary trigger for a message, which is returned to the plasma membrane resulting in the slow activation of "store-operated" Ca2+ entry channels (2, 4-6). This second Ca2+ entry phase of Ca2+ signals serves to mediate longer term cytosolic Ca2+ elevations and provides a means to replenish intracellular stores (2, 4). Whereas receptor-induced generation of InsP3 and the function of Ca2+ release channels to mediate the initial Ca2+ signaling phase is well understood, the mechanism for coupling ER Ca2+ store depletion with Ca2+ entry remains a crucial but unresolved question (4-6).

Direct coupling between ER and plasma membrane has been hypothesized (7, 8), and evidence indicates that physical docking of ER with the PM is involved in SOC activation (9-12). The mammalian TRP family of receptor-operated ion channels appear to share some operational parameters with SOCs (13, 14). Kiselyov et al. (15, 16) provided evidence that activation of the human TRP3 channel can result from an interaction with InsP3 receptors. Indeed, it appears that activation and maintenance of endogenous store-operated channels requires the InsP3 receptor (17). However, whereas members of the TRP family of proteins appear widely expressed (18, 19), their involvement in physiological store-operated Ca2+ entry remains uncertain (17, 20).

One complexity that hinders a unified understanding of store-operated Ca2+ entry is the heterogeneous nature of the process among different cell types. Although the Ca2+-selective current, ICRAC, is operational in some cells, a number of distinct store-operated currents of varying divalent cation selectivity have been described (4, 5). Also, significant differences in the activation and deactivation of store-operated Ca2+ entry have been observed among different cells (4, 21-24). In recent work (23, 24), we characterized a Ca2+ entry process activated by S-nitrosylation that can be stimulated by depletion of stores. In this report, we have compared the function and coupling of store-operated Ca2+ entry with operation of TRP3 channels and the S-nitrosylation-activated entry mechanism. The results indicate that whereas clear differences exist in the activation and coupling of these different entry mechanisms, there may nevertheless be underlying structural and functional similarities.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Culture of Cells-- DDT1MF-2 smooth muscle cells derived from hamster vas deferens were cultured in Dulbecco's modified Eagle's medium supplemented with 2.5% calf serum as described previously (25, 26); DC-3F Chinese hamster lung fibroblasts were cultured in alpha -modified Eagle's medium supplemented with 5% heat-inactivated fetal bovine serum as described previously (27, 28). The T3-65 clonal line of HEK293 cells were cultured as described recently (17).

Measurement of Intracellular Calcium-- Cells grown on coverslips for 1 day were transferred to Hepes-buffered Krebs medium (107 mM NaCl, 6 mM KCl, 1.2 mM MgSO4, 1 mM CaCl2, 1.2 mM KH2PO4, 11.5 mM glucose, 0.1% bovine serum albumin, 20 mM Hepes-KOH, pH 7.4) and loaded with fura-2/AM (2 µM) for 10 min at 20 °C. Cells were washed and dye allowed to deesterify for a minimum of 15 min at 20 °C. Approximately 95% of the dye was confined to the cytoplasm as determined by the signal remaining after saponin permeabilization (29, 30). Fluorescence emission at 505 nm was monitored with excitation at 340 and 380 nm; Ca2+ measurements are shown as 340/380 nm ratios obtained from a groups of 10-12 cells. Details of these Ca2+ measurements were described for DDT1MF-2 and (31) DC-3F cells (28) and the T3-65 clone of HEK293 cells (17). Resting Ca2+ levels in DDT1MF-2 cells were approximately 60-90 nM, 25-50 nM in DC-3F cells, and 50-100 nM in HEK293 cells. All measurements shown are representative of a minimum of three, and in most cases, a larger number of independent experiments.

Materials and Miscellaneous Procedures-- GEA3162 was from Alexis Corporation, San Diego, CA. Thapsigargin (TG) was from LC Services, Woburn, MA. Fura-2/acetoxymethylester was from Molecular Probes, Eugene, OR. Xestospongin C was from I. Pessah, University of California, Davis, CA), and 2-APB was from K. Mikoshiba, University of Tokyo. MDL-12,330A was from Calbiochem. OAG and other compounds were from Sigma.

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

We recently revealed that the activation of store-operated Ca2+ channels in the plasma membrane likely requires a physical interaction between the plasma membrane and endoplasmic reticulum membrane (9). In addition, evidence indicates that the InsP3 receptor is an essential component mediating the coupling between store emptying and the activation of store-operated channels (17). However, the activation of store-operated entry has proven an elusive process and the functional properties of store-operated channels can differ significantly between cell types. We determined recently that in some but not all cells, Ca2+ entry can be directly activated through a process mediated by S-nitrosylation (23). Since store depletion potentiates this process (23, 24), it was important to assess further its relationship to store-operated Ca2+ entry.

A useful tool in elucidating the coupling mechanism for SOC activation has been the cell-permeant InsP3 receptor blocker, 2-aminoethoxydiphenyl borate (2-APB) (17, 32, 33). In HEK293 cells 2-APB not only blocks receptor-induced Ca2+ release from stores but also blocks store-operated Ca2+ entry activated in response to depletion of pools with either receptor agonists or sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump inhibitors. In addition, 2-APB blocks receptor-induced activation of TRP3 channels in HEK293 cells stably transfected to express TRP3 channels (17). To investigate the role of InsP3 receptors in S-nitrosylation-mediated Ca2+ entry, experiments were first undertaken to assess the action of 2-APB on Ca2+ regulation in the DDT1MF-2 cell line in which there is a large Ca2+ entry response to S-nitrosylating conditions (23, 24). The action of 2-APB on store-operated Ca2+ entry in fura-2-loaded DDT1MF-2 cells is revealed in Fig. 1. Application of 1 µM thapsigargin induced a rapid release of Ca2+ from stores observed as a sharp rise in cytosolic Ca2+, followed by a second more slowly developing peak of cytosolic Ca2+ (Fig. 1A). The latter peak represents Ca2+ entry and was eliminated when the medium was replaced with nominally Ca2+-free external medium (Fig. 1B). Upon readdition of external Ca2+, entry of Ca2+ was transiently very large, representing the familiar "overshoot" response for store-operated Ca2+ channels (22, 28). If 75 µM 2-APB was added together with thapsigargin, it had little effect on the Ca2+ release component but completely blocked the Ca2+ entry component of the cytosolic Ca2+ signal response to thapsigargin (Fig. 1C). When 2-APB was added during the entry phase, it rapidly blocked entry (Fig. 1D). 2-APB is an effective cell-permeant inhibitor of the InsP3 receptor (17, 32, 33), and the blockade of store-operated Ca2+ entry caused by 2-APB appears to reflect the involvement of the InsP3 receptor in mediating and maintaining store-operated Ca2+ entry in DDT1MF-2 cells as in HEK293 cells (17). Another InsP3 receptor blocker, the natural product, xestospongin C, also blocks InsP3 receptor function (34) and similarly blocked Ca2+ entry in DDT1MF-2 cells (Fig. 1E). Although xestospongin C completely blocked entry, its action was much slower than 2-APB and required 20 min of treatment for a full effect. Both xestospongin C and 2-APB appear to have a similar mode of action. Evidence indicates that both molecules block the InsP3 receptor but do not interact directly with the InsP3 binding site (32, 34). Certainly, the similarity of action of the two molecules on Ca2+ entry provides good evidence that the action of both agents is related to their interaction with the InsP3 receptor. However, the similarity of action of two molecules with apparently rather different structures was curious (see Fig. 1). We undertook mass spectral analysis of 2-APB and determined that the predominant species of 2-APB under the conditions used appears to be a dimeric structure of molecular mass 450 Da, most likely involving the coordinate covalent bond shown in Fig. 1.2 This is a significantly more hydrophobic species than the monomer and likely accounts for the extremely rapid action of 2-APB in blocking InsP3 receptors (17). Also, the dimeric form of 2-APB does share some distant structural similarity to the xestospongin C molecule and may explain the similarity in their mode of action.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 1.   Store-operated Ca2+ entry into DDT1MF-2 cells is inhibited by 2-APB and xestospongin C. Cytosolic Ca2+ was measured in fura-2-loaded DDT1MF-2 cells as described under "Experimental Procedures." Standard conditions included 1 mM Ca2+ in the external medium; medium was replaced with nominally Ca2+-free medium (-Ca2+) for the times shown (bars). A, Ca2+ pools were depleted by adding the Ca2+ pump blocker, thapsigargin (TG) at 1 µM (arrow) followed by transient Ca2+ removal. B, 1 µM TG was added (arrow) in the absence of Ca2+, followed by the readdition of standard Ca2+. C, 1 µM TG (arrow) was added together with 75 µM 2-APB (bar) maintained through Ca2+ removal and readdition. D, Ca2+ pools were released with 1 µM TG, and 75 µM 2-APB was added later (bar). E, cells were pretreated for 20 min with 25 µM xestospongin C (xestC) in the presence of Ca2+ followed by 1 µM TG addition (arrow) and removal/readdition of Ca2+. Inset, three structures are presented: the monomer form of 2-APB (upper), the spectrally determined dimerized form of 2-APB (middle), and xestospongin C (lower).

The question of the relationship between S-nitrosylation-induced Ca2+ entry and store-operated Ca2+ entry was investigated using 2-APB. The typical operation of Ca2+ entry activated by these two processes is shown in Fig. 2A. Release and entry in response to thapsigargin application are shown, followed by induction of a Ca2+ overshoot by subsequent transient Ca2+ removal. The overshoot of Ca2+ entry rapidly diminished due to desensitization of the channel (9, 24). However, application of the lipophilic NO donor, GEA3162, induced a rapid and large further increase in Ca2+. This response is typical of the action of a number of different NO donors and alkylators (23) and is believed to reflect a Ca2+ entry mechanism activated through S-nitrosylation (23, 24). The Ca2+ entry response to GEA3162 is considerably potentiated by store depletion (23)and also by transient removal and readdition of extracellular Ca2+ (24). As seen in Fig. 2B, a large and rapid entry of Ca2+ occurs upon removal and readdition of Ca2+ in the presence of GEA3162 even though stores had not been emptied. The stimulation of NO donor-induced Ca2+ entry by both pool emptying and transient Ca2+ removal has suggested an intriguing similarity with store-operated Ca2+ channels (23, 24). However, there is an important difference between the two entry mechanisms. Thus, while the InsP3 receptor antagonist, 2-APB, completely blocks store-operated entry, it has little effect on the action of GEA3162 (Fig. 2C). In this experiment, 2-APB blocked the Ca2+ entry in response to store emptying with thapsigargin and the subsequent overshoot of Ca2+ entry, however, application of GEA3162 still gave a rapid and large Ca2+ entry response in the continued presence of 2-APB (Fig. 2C). Moreover, 2-APB did not diminish the GEA3162-dependent entry of Ca2+ following removal and readdition of Ca2+ (Fig. 2D).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   Store-operated Ca2+ entry is blocked by 2-APB, while Ca2+ entry induced by the NO donor, GEA3162, is insensitive to 2-APB. Experiments utilized DDT1MF-2 cells as described in the legend to Fig. 1. Bars indicate times of replacement of medium with nominally Ca2+-free medium (-Ca2+). A, 1 µM TG was added (arrow), followed by transient external Ca2+ removal and addition of 100 µM GEA3162 (GEA) as shown by bars. B, cells were treated with 100 µM GEA3162 in nominally Ca2+-free medium for 3 min, and 1 mM Ca2+ was added in the continued presence of GEA3162. C, cells in nominally Ca2+-free medium were treated and maintained with 75 µM 2-APB; after 3 min 1 µM TG was added followed by Ca2+ removal/readdition and addition of 100 µM MDL as shown by bars. D, cells in nominally Ca2+-free medium were treated and maintained with 100 µM GEA3162 together with and 75 µM 2-APB; after 3 min, Ca2+-containing medium was added.

These results suggested a fundamental difference between the function of SOCs and the NO donor-induced entry mechanism. Activation of SOCs appears to require the InsP3 receptor as a coupling intermediary. In contrast, the action of GEA3162 might be consistent with the NO donor having a direct effect on a channel in the membrane. The results are also consistent with the effects of calyculin A-induced rearrangement of cortical actin, which prevents SOC activation by separating ER and plasma membrane (9) but does not prevent the action of GEA3162 (24). We considered it important to assess whether GEA3162 works directly to modify a channel or whether other intermediaries or second messengers might be involved. Our previous work indicated that the NO donor was functioning independently of cyclic GMP (23). In evaluating the possible involvement of cyclic AMP we utilized a number of different adenylyl cyclase modifiers including the cycloalkyl lactamamide, MDL-12330A, which has been utilized widely as an irreversible adenylyl cyclase inhibitor (35-37). Surprisingly, as shown in Fig. 3, this agent was effective in blocking store-operated Ca2+ entry in a number of different cell types. In DDT1MF-2 cells, 100 µM MDL almost completely blocked both the entry phase following thapsigargin treatment and the subsequent overshoot response (Fig. 3, A-C). Very similar results were obtained in the DC-3F fibroblast line (Fig. 3, D-F) and in HEK293 cells (not shown). In the A7r5 smooth muscle line in which entry of Ca2+ is observed as a larger and more sustained increase in cytosolic Ca2+ following store emptying, the action of MDL was again to completely block Ca2+ entry (Fig. 3, G-I). In each cell line, the action of MDL appeared to be specifically on Ca2+ entry with little effect on basal Ca2+ levels or the size of releasable pools.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   Inhibition of store-operated Ca2+ entry by MDL-12,330A in different cell types. Experiments were undertaken as described in the legend to Fig. 1; bars indicate times of replacement of medium with nominally Ca2+-free medium (-Ca2+). A-C, using DDT1MF-2 cells, Ca2+ levels were monitored after TG addition (arrow) for the times shown in the absence (A, B) or presence (C) of 100 µM MDL-12,330A (MDL) maintained through the experiment (bar). D-F, as for A-C except using DC-3F cells. G-I, as for A-C except using A7r5 smooth muscle cells. Inset, structure of MDL-12,330A.

To evaluate the effect of MDL on store-operated Ca2+ entry we wished to know whether its actions were related to adenylyl cyclase activity. We therefore assessed the effects of another permeant adenylyl cyclase inhibitor, 2',5'-dideoxyadenosine (DDA). At 100 µM, DDA had no significant effect on store-operated Ca2+ entry (Fig. 4A). In other experiments (not shown), addition of the permeant cyclic AMP analogues, 8-bromo-cyclic AMP or 8-CPT-cyclic AMP, at concentrations up to 1 mM, either alone or in combination with MDL, had no significant effect on Ca2+ entry. Also, the adenylyl cyclase activator, forskolin, alone or in combination with the phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine, either with or without MDL, did not influence Ca2+ entry. The effects of MDL on adenylyl cyclase activity are reported to be irreversible (35). However, experiments revealed that the blocking action of MDL on Ca2+ entry could be readily reversed. When cells were treated with 100 µM MDL for 5 min followed by a wash in MDL-free medium for 10 min, store-operated Ca2+ entry returned (data not shown). After blocking Ca2+ entry induced by thapsigargin with MDL, Ca2+ entry returned within 3 min of washing away MDL (Fig. 4B). In this experiment, 100 µM MDL was added acutely with thapsigargin, and the entry phase of the Ca2+ response was eliminated. Both MDL and Ca2+ were removed for a 3-min period; upon Ca2+ readdition, a normal overshoot response was obtained. In combination, these results indicate that the inhibition of store-operated Ca2+ entry with MDL did not appear related to effects on either adenylyl cyclase activity or the levels of cyclic AMP in cells.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 4.   The inhibitory action of MDL-12,330A on store-operated Ca2+ entry is independent of adenylyl cyclase, reversible, and downstream of PLC-coupled receptor-induced Ca2+ release. Ca2+ changes in DDT1MF-2 cells were measured as described in the legend to Fig. 1 in nominally Ca2+-free medium for the times shown (bars). A, Ca2+ stores were depleted with 1 µM thapsigargin (TG) in the presence of the adenylyl cyclase inhibitor, 100 µM DDA, added 5 min prior to TG. B, 1 µM thapsigargin (TG) (arrow) was added concurrently with 50 µM MDL (bar); MDL was removed simultaneously with replacement of medium with nominally Ca2+-free medium. C, 1 µM bradykinin was added in the absence of external Ca2+, followed by the readdition of 1 mM Ca2+ medium. D, as for C except with 100 µM MDL throughout.

The above actions of MDL were to block Ca2+ entry in response to store emptying with the Ca2+ pump blocker thapsigargin. Physiologically, store emptying does not occur through pump blockade. Therefore, it was important to assess the actions of MDL on Ca2+ entry in response to agonist-induced Ca2+ release. Generation of InsP3 as a result of phospholipase C-coupled receptor activation results in a rapid release of Ca2+ from stores. Efficient receptor desensitization results in short-lived InsP3 increases, hence store emptying and subsequent Ca2+ entry can be very transient (9, 17). If agonist treatment is undertaken in the absence of external Ca2+, entry is prevented and stores remain at least partially empty (9). As shown in Fig. 4C, addition of bradykinin in the absence of external Ca2+ induced a rapid release of Ca2+. Readdition of Ca2+ resulted in store-operated Ca2+ entry albeit smaller than that observed following the irreversible pump blockade induced by thapsigargin. Addition of MDL 1 min prior to bradykinin addition completely blocked this entry response (Fig. 4D). Significantly, MDL had no effect on agonist-induced Ca2+ release, indicating that it does not inhibit receptor-activated phospholipase C activation nor does is alter the function of InsP3 receptors to release Ca2+. Moreover, since MDL does not change basal levels of Ca2+ in cells or the release of Ca2+ in response to agonists or thapsigargin, this indicates that it does not alter cellular Ca2+ homeostasis maintained by Ca2+ pumps or the size or operation of Ca2+ stores.

We examined the kinetics of MDL's inhibitory effect on store-operated Ca2+ entry in more detail. Ca2+ entry following thapsigargin addition was compared in the presence of different MDL levels added 5 min before thapsigargin. The responses in the presence of 0, 10, and 100 µM MDL are shown in Fig. 5, A, B, and C, respectively. The concentration dependence of the action of MDL on the component of Ca2+ entry induced by thapsigargin is shown in Fig. 5D. Significant inhibition was observable with 1 µM MDL, and its effects were half-maximal at approximately 10 µM. This may be significantly different to the sensitivity of adenylyl cyclase to MDL, the IC50 of which is reported as 250 µM (35). The time dependence for the action of MDL was assessed by examining the overshoot response which occurs almost instantaneously after Ca2+ readdition (Fig. 5E). The effect of 100 µM MDL added simultaneously with Ca2+ was not observable until approximately 1 min after addition (Fig. 5F). Added 1 min prior to Ca2+ readdition, the action of MDL was substantial but not full (Fig. 5G). The action of MDL was almost complete when added for 10 min before Ca2+ readdition (Fig. 5H). Therefore, the effect of MDL is slightly different from that of 2-APB, which blocks store-operated Ca2+ entry extremely rapidly (Fig. 1C).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5.   Sensitivity and reversibility of MDL-12,330A-induced inhibition of store-operated Ca2+ entry. Ca2+ changes in DDT1MF-2 cells were measured as described in the legend to Fig. 1 in nominally Ca2+-free medium for the times shown (bars). A, 1 µM thapsigargin (TG) was added at the time shown (arrow). B, cells were treated with 10 µM MDL for 5 min prior to TG addition. C, cells were treated with 100 µM MDL for 5 min prior to TG addition. D, semi-log plot of the concentration dependence of action of MDL on store-operated Ca2+ entry determined as in C and D; entry values were obtained from the area under the curve in the presence of MDL relative to a similar experiment undertaken in nominally Ca2+-free medium. E-H, cells depleted of stores with 1 µM TG in nominally Ca2+-free medium were supplied with medium containing 1 mM Ca2+ (bars) and 100 µM MDL (bars) at the times shown; E, without MDL; F, MDL added simultaneously with Ca2+; G, MDL added 1 min prior to Ca2+; H, MDL added 10 min prior to Ca2+.

Returning to the question of Ca2+ entry activated in response to S-nitrosylation, MDL is clearly an effective blocker of this entry response as well. Following store emptying with thapsigargin, the large increment in Ca2+ entry induced by GEA3162 (Fig. 6A) was completely blocked by the inclusion of 100 µM MDL added at the same time as thapsigargin (Fig. 6B). In this experiment, MDL had also almost completely blocked store-operated Ca2+ entry. If, after pool emptying, MDL was added simultaneously with GEA3162, the increase in entry was rapidly attenuated, and only a small transient increase in entry was seen (Fig. 6C). If, after pool emptying, MDL was added without GEA3162, the store-operated entry was inhibited with a similar time dependence (Fig. 6D). In normal store-filled cells, the entry of Ca2+ observed following GEA3162 addition without external Ca2+ and subsequent readdition of Ca2+ (Fig. 6E) was completely blocked by inclusion of MDL in the medium (Fig. 6F). The concentration dependence of the blocking action of MDL on GEA3162-induced entry (not shown) revealed a very similar sensitivity to that of store-operated Ca2+ entry, with an IC50 of approximately 10 µM.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 6.   MDL inhibits Ca2+ entry induced by S-nitrosylation in DDT1MF-2 cells. Ca2+ changes were measured as in Fig. 1. Bars indicate presence of 100 µM MDL or nominally Ca2+-free medium for the times shown. A, Ca2+ stores were depleted with 1 µM thapsigargin (TG) followed by addition of 100 µM GEA3162 (GEA) (arrow). B, as for A but in the presence of 100 µM MDL. C, as in B, but MDL was added simultaneously with GEA. D, 100 µM MDL was added alone. E, Ca2+ entry stimulated by 100 µM GEA3162 (added in the absence of external Ca2+) in normal, store-filled cells, after return of medium containing 1 mM Ca2+. F, as for E, in the presence of 100 µM MDL.

These results indicate that the blocking action of MDL on store-operated Ca2+ entry and entry activated in response to the NO donor, GEA3162, is very similar. We and others (13-15, 17) have recently determined that some functional parameters of store-operated Ca2+ channels are shared with members of the TRP family of proteins. Receptor-induced activation of the human TRP3 channel stably expressed in HEK293 cells appears to have a requirement for the InsP3 receptor (17), in agreement with earlier data (15). This requirement for the InsP3 receptor appears to be the same for store-operated channels (17). However, the two channels differ with respect to one important parameter, that is, their relationship to store emptying. Thus, we and others (17, 18, 38-40) did not observe any correlation between the operation of TRP3 channels and the emptying of stores, indicating that activation of the TRP3 channel, although requiring the InsP3 receptor, occurs through a more direct coupling process (17). In view of this difference, assessing any pharmacological relationship between the action of TRP3 channels and SOCs was important. As shown in Fig. 7, MDL clearly blocked TRP3 activity. In the T3-65 clonal HEK293 line stably expressing TRP3 channels, the operation of these channels could be specifically observed by examining Sr2+ entry (17). Thus, although the cells also contain SOCs, the latter do not allow passage of Sr2+ under these conditions. Therefore, Sr2+ entry following PLC-coupled receptor agonist activation was a reliable means for independently assessing only function of TRP3 channels (17). As shown in Fig. 7A, application of carbachol in these cells induced a transient release of Ca2+ from stores in the absence of external Ca2+. Application of external Sr2+ resulted in a rapid entry of Sr2+ mediated by the TRP3 channel. If MDL was applied at the start of the trace, the agonist-induced release of Ca2+ was essentially unaffected, whereas the entry of Sr2+ was completely eliminated (Fig. 7B). Added during the sustained entry of Sr2+ mediated by the TRP3 channel, MDL terminated the channel activity (Fig. 7C). If MDL was added simultaneously with Sr2+ addition, there was a brief increase in Sr2+ entry which disappeared shortly after (Fig. 7D). Therefore, it is clear that MDL blocks receptor-induced activation of the TRP3 channel and that sensitivity to MDL is a property shared by TRP3 and store-operated Ca2+ entry channels.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 7.   Inhibition of Sr2+ entry through hTRP3 channels stably transfected in HEK293 cells. Ca2+ measurements using the T3-65 clone of HEK293 cells were as in Fig. 1; bars indicate times of replacement of nominally divalent cation-free medium with medium containing 1 mM Sr2+ and/or addition of 100 µM MDL. A, TRP3 channels were activated by addition of 100 µM carbachol (CCh) followed by addition of 1 mM Sr2+. B, as in A, in the presence of 100 µM MDL. C, as in A, but MDL added during sustained Sr2+ entry. D, as in A, but MDL added concurrently with Sr2+.

In a recent report, Hofmann et al. (40) revealed that certain TRP channels, including the TRP3 channel, could be directly activated by diacylglycerol, and this effect was quite independent of protein kinase C activation. The conclusion from this study was that DAG, and not InsP3, was the PLC-derived product responsible for agonist-induced activation TRP3 channels (40). However, our results indicated that TRP3 channels could be activated by both PLC-derived products (17). As shown in Fig. 8A, the membrane permeant DAG analogue, OAG, induced a clear activation of the TRP3 channel. This property of the TRP3 channel is quite distinct from SOC, which is insensitive to DAG analogues (17). The InsP3 receptor blocker 2-APB did not alter OAG-induced activation of TRP3 channels (Fig. 8B), suggesting that DAG may activate the channel directly and independently from the InsP3 receptor (17). In contrast, inclusion of MDL in the medium prior to OAG addition almost completely eliminated the OAG response (Fig. 8C). This provides useful further evidence that OAG is indeed acting on the TRP3 channel. When added simultaneously with OAG, the action of MDL was significantly diminished (Fig. 8D), that is, it was less effective in blocking. If MDL was added after OAG-induced TRP3 activation the inhibitory action of MDL was yet further reduced (not shown). The results suggest that both MDL and OAG may directly modify the TRP3 channel. Considering the diminished ability of MDL to reverse prior activation by OAG (in contrast to its very rapid termination of TRP3 activated by carbachol, as shown in Fig. 7C), it is possible that the diacylglycerol and MDL compete for a common site of action.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 8.   MDL and 2-APB have differing effects on the activation of hTRP3 by the diacylglycerol analogue, OAG. Experiments using the T3-65 clone of HEK293 cells were performed in the presence of 1 mM external Sr2+ and in the presence of 100 µM MDL or 75 µM 2-APB, as shown. A, TPR3 channels were activated by addition of 100 µM OAG (arrow). B, as in A, but in the presence of 2-APB added for 2.5 min prior to OAG. C, as in A, but in the presence of 100 µM MDL added 4 min prior to OAG. D, as in C, but MDL added simultaneously with OAG.

Overall, the results presented here provide some interesting similarities and differences in the operation of three distinct but related Ca2+ entry mechanisms. The coupling mechanism by which store-operated Ca2+ entry is activated has proven elusive. Most likely, the process involves "conformational coupling" between components of the ER and plasma membrane (7-9), and it appears that the InsP3 receptor is a required ER component mediating the coupling process (15, 17). A significant problem in assessing operation of store-operated entry is its apparent heterogeneity between cells perhaps indicating that a number of related channels can be store-coupled. Here we have compared endogenous store-operated Ca2+ entry with two other distinct but related entry mechanisms. The TRP3-mediated Ca2+ entry operates independently of stores, yet its activation appears to require the InsP3 receptor. The S-nitrosylationdependent entry mechanism is potentiated by store emptying but appears to reflect a direct activation process not mediated or maintained by the InsP3 receptor; this may indicate that coupling between stores and entry channels is not always mediated by the InsP3 receptor. Whereas these distinctions in coupling exist, a common feature of all three entry mechanisms is their sensitivity to the cycloalkyl lactamimide blocker, MDL-12,330A. Whereas sensitivity in the 10 µM range may not indicate a high affinity interaction, the similarity of sensitivity of the entry mechanisms to MDL is a significant finding. It should also be considered that, thus far, few reliable direct modifiers of store-operated entry have been identified. The econozoles, including SKF93635, have been utilized as blockers (42); however, our analysis of econozole action indicates great variation in their effectiveness between different cell types. In some cells SKF96365 may block in the high micromolar range (28), whereas in others there is little effect on Ca2+ entry and/or spurious changes in fluorescence.3 The reason for this variation is unclear but may reflect differences in channel subtypes and/or coupling state. In contrast, the action of MDL is very reliable between cells. Interestingly, there have been reports of direct actions of MDL in the low micromolar range on voltage-operated Ca2+ channels (41, 43, 44), suggesting that there may be some wider structural relationship between Ca2+ entry channels. Any relationship between these entry mechanisms might be further elucidated from examination of the actions of molecules structurally related to MDL.

    ACKNOWLEDGEMENTS

We thank Dr. Cecile Favre and Dr. Carmen Ufret-Vincenty for help in the early part of these studies, Dr. Katsuhiko Mikoshiba for supplying 2-APB, Dr. Lutz Birnbaumer for providing the transfected HEK293 cells, Dr. David Christianson for helpful structural advice, and Dr. Hee-Yong Kim for mass spectral analysis of the 2-APB molecule.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant HL55426, a fellowship from the Interdisciplinary Muscle Training Program (to R. L. P.), and a fellowship (to H.-T. M.) from the American Heart Association, Maryland Affiliate.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger The contribution of these two authors was equal.

§ To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene St., Baltimore, MD 21201. Tel.: 410-706-2593 (office) or -7247 (laboratory); Fax: 410-706-6676; E-mail, dgill@umaryland.edu.

Published, JBC Papers in Press, June 30, 2000, DOI 10.1074/jbc.M003147200

2 D. L. Gill and H.-Y. Kim, unpublished observations.

3 R. L. Patterson and D. L. Gill, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: ER, endoplasmic reticulum; InsP3, inositol 1,4,5-trisphosphate; NO, nitric oxide; fura-2/AM, fura-2 acetoxymethylester; GEA3162, (5-amino-3-(3,4-dichlorophenyl)1,2,3,4-oxatriazolium); MDL-12, 330A, cis-N-(2-phenylcyclopentyl)azacyclotridec-1-en-2-amine; 2-APB, 2-aminoethoxydiphenyl borate; DDA, 2',5'-dideoxyadenosine; PLC, phospholipase C; DAG, diacylglycerol; OAG, 1-oleoyl-2-acetyl-sn-glycerol; SKF96365, 1-[beta -[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl]-1H-imidazole; TG, thapsigargin.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1. Berridge, M. J., Bootman, M. D., and Lipp, P. (1998) Nature 395, 645-648
2. Putney, J. W., and Bird, G. S. (1993) Cell 75, 199-201
3. Clapham, D. E. (1995) Cell 80, 259-268
4. Parekh, A. B., and Penner, R. (1997) Physiol. Rev. 77, 901-930
5. Putney, J. W., and McKay, R. R. (1999) Bioessays 21, 38-46
6. Gill, D. L., Waldron, R. T., Rys-Sikora, K. E., Ufret-Vincenty, C. A., Graber, M. N., Favre, C. J., and Alfonso, A. (1996) Biosci. Rep. 16, 139-157
7. Irvine, R. F. (1990) FEBS Lett. 263, 5-9
8. Berridge, M. J. (1995) Biochem. J. 312, 1-11
9. Patterson, R. L., van Rossum, D. B., and Gill, D. L. (1999) Cell 98, 487-499
10. Putney, J. W. J. (1999) Cell 99, 5-8
11. Yao, Y., Ferrer-Montiel, A. V., Montal, M., and Tsien, R. Y. (1999) Cell 98, 475-485
12. Rosado, J. A., Jenner, S., and Sage, S. O. (2000) J. Biol. Chem. 275, 7527-7533
13. Zhu, X., Jiang, M., Peyton, M., Boulay, G., Hurst, R., Stefani, E., and Birnbaumer, L. (1996) Cell 85, 661-671
14. Montell, C. (1999) Annu. Rev. Cell Dev. Biol. 15, 231-268
15. Kiselyov, K., Xu, X., Mohayeva, G., Kuo, T., Pessah, I. N., Mignery, G. A., Zhu, X., Birnbaumer, L., and Muallem, S. (1998) Nature 396, 478-482
16. Kiselyov, K., Mignery, G. A., Zhu, M. X., and Muallem, S. (1999) Mol. Cell 4, 423-429
17. Ma, H.-T., Patterson, R. L., van Rossum, D. B., Birnbaumer, L., Mikoshiba, K., and Gill, D. L. (2000) Science 287, 1647-1651
18. Li, H. S., Xu, X. Z., and Montell, C. (1999) Neuron 24, 261-273
19. Liu, X., Wang, W., Singh, B. B., Lockwich, T., Jadlowiec, J., O' Connell, B., Wellner, R., Zhu, M. X., and Ambudkar, I. S. (2000) J. Biol. Chem. 275, 3403-3411
20. Berridge, M. J., Lipp, P., and Bootman, M. D. (2000) Science 287, 1604-1605
21. Louazo, C. M., Ribeiro, C. M. P., Bird, G., St, J., and Putney, J. W., Jr. (1996) J. Biol. Chem. 271, 14807-14813
22. Ufret-Vincenty, C. A., Short, A. D., Alfonso, A., and Gill, D. L. (1995) J. Biol. Chem. 270, 26790-26793
23. Favre, C. J., Ufret-Vincenty, C. A., Stone, M. R., Ma, H.-T., and Gill, D. L. (1998) J. Biol. Chem. 273, 30855-30858
24. Ma, H.-T., Favre, C. J., Patterson, R. L., Stone, M. R., and Gill, D. L. (1999) J. Biol. Chem. 274, 35318-35324
25. Ghosh, T. K., Mullaney, J. M., Tarazi, F. I., and Gill, D. L. (1989) Nature 340, 236-239
26. Ghosh, T. K., Bian, J., and Gill, D. L. (1990) Science 248, 1653-1656
27. Waldron, R. T., Short, A. D., and Gill, D. L. (1995) J. Biol. Chem. 270, 11955-11961
28. Waldron, R. T., Short, A. D., and Gill, D. L. (1997) J. Biol. Chem. 272, 6440-6447
29. Short, A. D., Klein, M. G., Schneider, M. F., and Gill, D. L. (1993) J. Biol. Chem. 268, 25887-25893
30. Short, A. D., Bian, J., Ghosh, T. K., Waldron, R. T., Rybak, S. L., and Gill, D. L. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 4986-4990
31. Graber, M. N., Alfonso, A., and Gill, D. L. (1997) J. Biol. Chem. 272, 29546-29553
32. Maruyama, T., Kanaji, T., Nakade, S., Kanno, T., and Mikoshiba, K. (1997) J. Biochem. (Tokyo) 122, 498-505
33. Maruyama, T., Cui, Z., Kanaji, T., Mikoshiba, K., and Kanno, T. (1997) Biomed. Res. 18, 297-302
34. Gafni, J., Munsch, J. A., Lam, T. H., Catlin, M. C., Costa, L. G., Molinski, T. F., and Pessah, I. N. (1997) Neuron 19, 723-733
35. Guellaen, G., Mahu, J. L., Mavier, P., Berthelot, P., and Hanoune, J. (1977) Biochim. Biophys. Acta 484, 465-475
36. Grupp, G., Grupp, I. L., Johnson, C. L., Matlib, M. A., Rouslin, W., Schwartz, A., Wallick, E. T., Wang, T., and Wisler, P. (1980) Br. J. Pharmacol. 70, 429-442
37. Correia-de-Sa, P., and Ribeiro, J. A. (1994) Eur. J. Pharmacol. 271, 349-355
38. Zitt, C., Obukhov, A. G., Strübing, C., Zobel, A., Kalkbrenner, F., Lückhoff, A., and Schultz, G. (1997) J. Cell Biol. 138, 1333-1341
39. Zhu, X., Jiang, M., and Birnbaumer, L. (1998) J. Biol. Chem. 273, 133-142
40. Hofmann, T., Obukhov, A. G., Schaefer, M., Harteneck, C., Gudermann, T., and Schultz, G. (1999) Nature 397, 259-263
41. Rampe, D., Poder, T., Zhao, Z. Y., and Schilling, W. P. (1989) J. Cardiovasc. Pharmacol. 13, 547-556
42. Merritt, J. E., Armstrong, W. P., Benham, C. D., Hallam, T. J., Jacob, R., Jaxa-Chamiec, A., Leigh, B. K., McCarthy, S. A., Moores, K. E., and Rink, T. J. (1990) Biochem. J. 271, 515-522
43. Lee, H. R., Jaros, J. A., Roeske, W. R., Wiech, N. L., Ursillo, R., and Yamamura, H. I. (1985) J. Pharmacol. Exp. Ther. 233, 611-616
44. Rampe, D., Triggle, D. J., and Brown, A. M. (1987) J. Pharmacol. Exp. Ther. 243, 402-407


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. Zhang, T. A. Roepke, M. J. Kelly, and O. K. Ronnekleiv
Kisspeptin Depolarizes Gonadotropin-Releasing Hormone Neurons through Activation of TRPC-Like Cationic Channels
J. Neurosci., April 23, 2008; 28(17): 4423 - 4434.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Essin, A. Welling, F. Hofmann, F. C. Luft, M. Gollasch, and S. Moosmang
Indirect coupling between Cav1.2 channels and ryanodine receptors to generate Ca2+ sparks in murine arterial smooth muscle cells
J. Physiol., October 1, 2007; 584(1): 205 - 219.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Zhang, H. H. Patel, F. Murray, C. V. Remillard, C. Schach, P. A. Thistlethwaite, Paul. A. Insel, and J. X.-J. Yuan
Pulmonary artery smooth muscle cells from normal subjects and IPAH patients show divergent cAMP-mediated effects on TRPC expression and capacitative Ca2+ entry
Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1202 - L1210.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. Y. Hung and N. S. Magoski
Activity-Dependent Initiation of a Prolonged Depolarization in Aplysia Bag Cell Neurons: Role for a Cation Channel
J Neurophysiol, March 1, 2007; 97(3): 2465 - 2479.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. T. Lanner, A. Katz, P. Tavi, M. E. Sandstrom, S.-J. Zhang, C. Wretman, S. James, J. Fauconnier, J. Lannergren, J. D. Bruton, et al.
The role of Ca2+ influx for insulin-mediated glucose uptake in skeletal muscle.
Diabetes, July 1, 2006; 55(7): 2077 - 2083.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. R. Cima, J. M. Dubach, A. M. Wieland, B. M. Walsh, and D. I. Soybel
Intracellular Ca2+ and Zn2+ signals during monochloramine-induced oxidative stress in isolated rat colon crypts
Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G250 - G261.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Dobrydneva, C. J. Abelt, B. Dovel, C. M. Thadigiri, R. L. Williams, and P. F. Blackmore
2-Aminoethoxydiphenyl Borate as a Prototype Drug for a Group of Structurally Related Calcium Channel Blockers in Human Platelets
Mol. Pharmacol., January 1, 2006; 69(1): 247 - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yang, S. Mergler, X. Sun, Z. Wang, L. Lu, J. A. Bonanno, U. Pleyer, and P. S. Reinach
TRPC4 Knockdown Suppresses Epidermal Growth Factor-induced Store-operated Channel Activation and Growth in Human Corneal Epithelial Cells
J. Biol. Chem., September 16, 2005; 280(37): 32230 - 32237.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. G. Egan, C. L. Wainwright, R. M. Wadsworth, and G. F. Nixon
PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: Effects of altered intracellular Ca2+ regulation
Cardiovasc Res, August 1, 2005; 67(2): 308 - 316.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-P. He, T. Hewavitharana, J. Soboloff, M. A. Spassova, and D. L. Gill
A Functional Link between Store-operated and TRPC Channels Revealed by the 3,5-Bis(trifluoromethyl)pyrazole Derivative, BTP2
J. Biol. Chem., March 25, 2005; 280(12): 10997 - 11006.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Dong, Z. M. Sellers, A. Smith, J. Y. C. Chow, and K. E. Barrett
Na+/Ca2+ exchange regulates Ca2+-dependent duodenal mucosal ion transport and HCO3- secretion in mice
Am J Physiol Gastrointest Liver Physiol, March 1, 2005; 288(3): G457 - G465.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. W. Slice, T. Chiu, and E. Rozengurt
Angiotensin II and Epidermal Growth Factor Induce Cyclooxygenase-2 Expression in Intestinal Epithelial Cells through Small GTPases Using Distinct Signaling Pathways
J. Biol. Chem., January 14, 2005; 280(2): 1582 - 1593.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. G. J. Hoenderop, B. Nilius, and R. J. M. Bindels
Calcium Absorption Across Epithelia
Physiol Rev, January 1, 2005; 85(1): 373 - 422.
[Abstract] [Full Text] [PDF]